
|Articles|January 1, 2007
Time will define Juvederm's place among HA fillers
National report - Many in dermatology are anxiously anticipating the arrival of the latest addition to the hyaluronic acid filler market, Juvederm (Allergan Medical), as a new alternative to the long-held gold standard, Restylane (Medicis ?sthetics).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
2
Transformative Advances This Year and Beyond
3
KT-621 Produces 98% STAT6 Degradation in AD Patients
4
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
5



















